Protection from type 1 diabetes in the face of high levels of activated autoaggressive lymphocytes in a viral transgenic mouse model crossed to the SV129 strain

Diabetes

Volumn 50, Issue 12, 2001, Pages 2700-2708

  Von Herrath, Matthias G ^a,b   Wolfe, Tom ^a   Möhrle, Ursula ^a   Coon, Bryan ^a   Hughes, Anna ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

H 2 ANTIGENS; H2 ANTIGEN; HISTOCOMPATIBILITY ANTIGEN H 2D(B); HISTOCOMPATIBILITY ANTIGEN H-2D(B); INSULIN;

ANIMAL; ARTICLE; AUTOIMMUNE DISEASE; CROSS BREEDING; CYTOTOXIC T LYMPHOCYTE; GENETICS; IMMUNITY; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE; LYMPHOCYTE COUNT; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; MOUSE STRAIN; PANCREAS ISLET; PROMOTER REGION; RAT; T LYMPHOCYTE; TRANSGENIC MOUSE; VIROLOGY;

ANIMAL; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CROSSES, GENETIC; DIABETES MELLITUS, INSULIN-DEPENDENT; H-2 ANTIGENS; IMMUNITY, NATURAL; INSULIN; ISLETS OF LANGERHANS; LYMPHOCYTE COUNT; LYMPHOCYTES; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, TRANSGENIC; PROMOTER REGIONS (GENETICS); RATS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0035650535     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.12.2700     Document Type: Article

References (43)

1. Bach, J.-F: Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 15:516-542, 1994
2. Hiemstra HS, Drijfhout JW, Roep BO: Antigen arrays in T cell immunology. Curr Opin Immunol 12:80-84, 2000
3. Hawkes CJ, Schloot NC, Marks J, Willemen SJ, Drijfhout JW, Mayer EK, Christie MR, Roep BO: T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetes. Diabetes 49:356-366, 2000
4. Roep BO, Stobbe I, Duinkerken G, van Rood JJ, Lernmark A, Keymeulen B, Pipeleers D, Claas FH, de Vries RR: Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes 48: 484-490, 1999
5. Sevilla N, Homann D, von Herrath MG, Rodriguez F, Harkins S, Whitton JL, Oldstone MBA: Virus-induced diabetes in a transgenic model: role of cross-reacting viruses and quantitation of effector T cells needed to cause disease. J Virol 74:3284-3292, 2000
6. von Herrath MG, Coon B, Lewicki H, Mazarguil H, Gairin JE, Oldstone MBA: In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes. J Immunol 161:5087-5096, 1998
7. Wong FS, Karttunen J, Dumont C, Wen L, Visintin I, Pilip IM, Shastri N, Pamer EG, Janeway CA Jr: Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nature Med 5:1026-1031, 1999
8. Tisch R, McDevitt HO: Antigen-specific immunotherapy: is it a real possibility to combat T-cell-mediated autoimmunity? Proc Natl Acad Sci U S A. 91:437-438, 1994
9. + T cell deletion induced by cross-presentation of self antigens and favors autoimmunity. J Exp Med 186: 2057-2062, 1997
10. Genain C, Lee-Parritz D, Nguyen M, Massacesi L, Joshi N, Ferrante R, Hoffman K, Moseley K, Letvin N, Hauser S: In healthy primates, circulating autoreactive T-cells mediate autoimmune disease. J Clin Invest 94:1339-1345, 1994
11. von Herrath MG, Guerder S, Lewicki H, Flavell R, Oldstone MBA: Coexpression of B7.1 and viral (self) transgenes in pancreatic β-cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes. Immunity 3:727-738, 1995
12. Tisch R, Yang XD, Singer SM, Liblau RS, Fugger L, McDevitt HO: Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366:72-75, 1993
13. Morgan DJ, Liblau R, Scott B, Fleck S, McDevitt HO, Sarvetnick N, Lo D, Sherman LA: CD8(+) T cell-mediated spontaneous diabetes in neonatal mice. J Immunol 157:978-983, 1996
14. Sechler JMG, Yip JC, Rosenberg AS: Genetic variation among 129 substrains: practical consequences. J Immunol 159:5766-5768, 1997
15. + T cell activation and tolerance induction in B cell knockout mice. J Exp Med 183:1339-1344, 1996
16. Dalton DK, Pitts-Meek S, Keshav S, Figari I, Bradley A, Stewart TA: Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259:1739-1742, 1993
17. Probert L, Akassoglou K, Kassiotis G, Pasparakis M, Alexopoulou L, Kollias G: TNF-alpha transgenic and knockout models of CNS inflammation and degeneration. J Neuroimmunol 72:137-141, 1997
18. Wong FS, Dittel BN, Janeway CA Jr: Transgenes and knockout mutations in animal models of type 1 diabetes and multiple sclerosis. Immunol Rev 169:93-104, 1999
19. Holz A, Dyrberg T, Hagopian W, Homann D, von Herrath M, Oldstone MB: Neither B lymphocytes nor antibodies directed against self antigens of the islets of Langerhans are required for development of virus-induced autoimmune diabetes. J Immunol 15:5945-5953, 2000:
20. Ohashi P, Oehen S, Buerki K, Pircher H, Ohashi C, Odermatt B, Malissen B, Zinkernagel R, Hengartner H: Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65:305-317, 1991
21. Oldstone MBA, Nerenberg M, Southern P, Price J, Lewicki H: Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 65:319-331, 1991
22. Seewaldt S, Thomas HE, Ejrnaes M, Christen U, Wolfe T, Rodrigo E, Coon B, Michelsen B, Kay TWH, von Herrath MG: Virus-induced autoimmune diabetes: most β-cells die through inflammatory cytokines and not perform from autoreactive (anti-viral) cytotoxic T-lymphocytes. Diabetes 49:1801-1809, 2000
23. von Herrath MG, Holz A: Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM. J Autoimmun 10:231-238, 1997
24. von Herrath MG, Oldstone MBA: IFN-gamma is essential for beta-cell destruction by CTL J Exp Med 185:531-539, 1997
25. Kagi D, Odermatt B, Ohashi PS, Zinkernagel RM, Hengartner H: Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity. J Exp Med 183:2143-2152, 1996
26. + T cells during acute infection with lymphocytic choriomeningitis virus. J Immunol 161:3215-3218, 1998
27. b major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes. J Virol 69:2297-2305, 1995
28. von Herrath MG, Yokoyama M, Dockter J, Oldstone MBA, Whitton JL: CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. J Virol 70:1072-1079, 1996
29. Van De Winkel M, Maes E, Pipeleers D: Islet cell analysis and purification by light scatter and autofluorescence. Biochem Biophys Res Commun 107:525-532, 1982
30. Van De Winkel M, Pipeleers D: Autofluorescence-activated cell sorting of pancreatic islet cells: purification of insulin-containing B-cells according to glucose-induced changes in cellular redox state. Biochem Biophys Res Commun 114:835-842, 1983
31. von Herrath MG, Dyrberg T, Oldstone MBA: Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice. J Clin Invest 98:1324-1331, 1996
32. Thomas HE, Parker JL, Schreiber RD, Kay TWH: IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes. J Clin Invest 102:1249-1257, 1998
33. von Herrath MG, Dockter J, Nerenberg M, Gairin JE, Oldstone MBA: Thymic selection and adaptability of cytotoxic T lymphocyte responses in transgenic mice expressing a viral protein in the thymus. J Exp Med 180:1901-1910, 1994
34. von Herrath MG, Dockter J, Oldstone MBA: How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity 1:231-242, 1994
35. von Herrath MG, Coon B, Oldstone MBA: Low-affinity cytotoxic T-lymphocytes requires IFN-gamma to clear an acute viral infection. Virology 229:349-359, 1997
36. Homann D, Holz A, Bot A, Coon B, Wolfe T, Petersen J, Dyrberg TP, Grusby MJ, von Herrath MG: Autoreactive CD4+ lymphocytes protect from autoimmune diabetes via bystander suppression using the IL-4/STAT6 pathway. Immunity 11:463-472, 1999
37. Oxenius A, Zinkemagel RM, Hengartner H: Comparison of activation versus induction of unresponsiveness of virus-specific CD4+ and CD8+ T cells upon acute versus persistent viral infection. Immunity 9:449-457, 1998
38. van der Most RG, Murali-Krishna K, Whitton JL, Oseroff C, Alexander J, Southwood S, Sidney J, Chesnut RW, Sette A, Ahmed R: Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice. Virology 240:158-167, 1998
39. Murali-Krishna K, Altman JD, Suresh M, Sourdive DJD, Zajac AJ, Miller JD, Slansky J, Ahmed R: Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177-187, 1998
40. Whitton JL, Southern PJ, Oldstone MBA: Analysis of the CTL responses to glycoprotein and nucleoprotein components of LCMV. J Virol 67:2903-2907, 1993
41. Murali-Krishna K, Altman JD, Suresh M, Sourdive D, Zajac A, Ahmed R: In vivo dynamics of anti-viral CD8 T cell responses to different epitopes: an evaluation of bystander activation in primary and secondary responses to viral infection. Adv Exp Med Biol 452:123-142, 1998
42. Nguyen LT, McKall-Faienza K, Zakarian A, Speiser DE, Mak TW, Ohashi PS: TNF receptor 1 (TNFR1) and CD95 are not required for T cell deletion after virus infection but contribute to peptide-induced deletion under limited conditions. Eur J Immunol 30:683-688, 2000
43. Oldstone MBA, von Herrath M, Lewicki H, Hudrisier D, Whitton JL, Gairin E: Use of a high-affinity peptide that aborts MHC-restricted cytotoxic T lymphocyte activity against multiple viruses in vitro and virus-induced immunopathologic disease in vivo. Virology 256:246-257, 1999